Cure Forward has partnered with these labs to allow you to easily access your data. Together we are making it easier for you to put your data to work.

If you have not had a molecular test done, we recommended using these resources to get tested and receive the data that belongs to you.

PGD Personal Genome Diagnostics
Paradigm diagnostic testing logo
Symbiodix pathology & genetic sequencing
Cynvenio genomic analysis of tumor cells
Emory University Genetics Laboratory
Diagnostic testing & clinical research lab at Knight Cancer Institute of Oregon Health & Science University
Med Fusion Oncology Clinical Labs & Clinical Trials
OmniSeq.logo_.2c.new_-1
PGD Personal Genome Diagnostics

Personal Genome Diagnostics (PGDx) advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. The expert team at PGDx draws on a deep understanding of cancer biology and extensive experience in cancer genomics and clinical oncology to pioneer genomic methods. These novel technologies precisely identify and characterize unique genomic alterations in tumors. PGDx is working toward broad patient access to their life-saving methods through both a CLIA-certified facility providing a comprehensive genomic service menu. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are internationally recognized leaders in cancer genomics who have extensive experience in the practical application of advanced genomic technologies to research, drug development and clinical practice. For physicians and patients, PGDx Clinical Services offers actionable insights to inform treatment and clinical trial enrollment decisions in both tissue and plasma.

Visit PDGx at www.personalgenome.com/

Paradigm diagnostic testing logo

Paradigm brings cutting-edge diagnostics and biomarker-driven clinical trials to benefit cancer patients. Through Next-Gen Sequencing (NGS), and other biomarker analysis, the Paradigm Cancer Diagnostic (PCDx) test is able to provide the treating clinician with information about the genomic and proteomic landscape of a patient’s cancer, helping personalize each patient’s course of treatment.

Visit Paradigm at www.paradigmdx.org/

Symbiodix pathology & genetic sequencing

Symbiodx is a national anatomic pathology and molecular oncology reference laboratory committed to helping pathologists and oncologists provide critical answers in treatment planning and improving patient outcomes.  The company was formed in 2013 by PAML and CellNetix to provide esoteric testing and consultation services to other pathology and oncology groups in the national arena.

Visit Symbiodx at www.symbiodx.com

Cynvenio genomic analysis of tumor cells

Cynvenio is a cancer diagnostics company focused on the molecular analysis of cancer biomarkers in blood, especially where traditional tissue pathology may fall short. Cynvenio opens a new treatment window for metastatic patients who are unresponsive to second or third line therapy; or where it is desirable to serially test patients to monitor their response to therapy without subjecting them to frequent radiology procedures.

Visit Cynvenio at www.cynvenio.com/

Emory University Genetics Laboratory

Emory Genetics Laboratory is led by a highly experienced and knowledgeable team of laboratory directors, who are pioneers in the field of human genetics. Their expertise spans the fields of molecular biology, cytogenetics, biochemical genetics, rare-disease testing, and comprehensive testing for newborn screening follow-up.

Visit Emory Genetics Laboratory at http://geneticslab.emory.edu/

Diagnostic testing & clinical research lab at Knight Cancer Institute of Oregon Health & Science University

Knight Diagnostic Laboratories leverages the rapid advances in diagnostic testing to make that personalized medicine a reality. It also develops industry-leading methods for disease diagnosis. Offering a wide menu of molecular and genetic tests for oncology, infectious diseases, and rare genetic disorders, Knight Diagnostic Laboratories helps physicians deliver individualized, specific, and accurate diagnoses. Through collaborative partnerships with leading industry and academic institutions, they provide unique access to the very latest advances in diagnostic testing.

Visit Knight Diagnostic Laboratories at www.knightdxlabs.com/

Med Fusion Oncology Clinical Labs & Clinical Trials

med fusion is a leader in advanced laboratory and clinical trials services providing full spectrum diagnostics across the continuum of care in Oncology, Women’s Health and Urology. Using cutting edge technology and bioinformatic solutions to better diagnose, identify and target specific disease characteristics, their integrated approach translates to more effective and efficient patient care making precision medicine possible.

Visit Med Fusion at  http://medfusionservices.com/whatwedo/oncology/

OmniSeq.logo_.2c.new_-1

OmniSeq is a CLIA and NYS CLEP certified molecular laboratory that is committed to improving access to the most informative molecular tumor profiling insights to help guide comprehensive cancer care. Our clinical reports highlight therapeutic options that are backed by the highest levels of evidence, including clinical practice guidelines and published data, allowing us to identify the most actionable genes and variants that can help guide the best possible clinical treatment decisions. We are an extension of your team. The OmniSeq CARES Service Program focuses on both the physician and patient experience by facilitating everything from sample retrieval and clinical consultation, to insurance navigation, financial assistance and clinical trial access, offering full support every step of the way.

Visit OmniSeq at www.omniseq.com/

The Human and Molecular Genetics Center at the Medical College of Wisconsin is a world leader in next generation sequencing data generation and data analysis. We are one of the first diagnostic laboratories in the United States to offer Whole Genome Sequencing as a clinical test. We specialize in using Whole Genome Sequencing and Whole Exome Sequencing as a tool to determine a patient’s risk of hereditary cancer. We believe that personalized medicine begins with cancer risk assessment and treatment. The HMGC basic and clinical scientists lead the efforts at the Medical College of Wisconsin to provide quality precision medicine and health care by enabling researchers and clinicians to use genome sequence to understand disease, improve diagnosis, and advance the treatment of patients. Our CLIA-certified laboratory performs whole exome and whole genome sequencing, robust data analysis, and validation for precision diagnostics and therapeutics in pediatric and adult patients.

Visit Medical College of Wisconsin at www.mcw.edu

Your Right To Your Data

You have the right to access and use your medical data in any way you wish. It’s important to know that with any test you have done, you can request a copy for your files. At Cure Forward, we help you use molecular profiling results to find clinical trials and learn about the most recent medical developments. If you have had a test done at any of the above labs, or any other lab, we can help you.

Together We Are Stronger.

Being diagnosed with cancer is an overwhelming experience. Our goal is to help you understand and identify cancer treatment options you might not have found on your own. Get started below and we’ll partner with you to determine your next step.

Have Questions?
Healthcare Providers